José L. López-Ribot

20.1k total citations · 7 hit papers
194 papers, 15.9k citations indexed

About

José L. López-Ribot is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, José L. López-Ribot has authored 194 papers receiving a total of 15.9k indexed citations (citations by other indexed papers that have themselves been cited), including 162 papers in Infectious Diseases, 80 papers in Molecular Biology and 77 papers in Epidemiology. Recurrent topics in José L. López-Ribot's work include Antifungal resistance and susceptibility (158 papers), Fungal Infections and Studies (71 papers) and Bacterial biofilms and quorum sensing (55 papers). José L. López-Ribot is often cited by papers focused on Antifungal resistance and susceptibility (158 papers), Fungal Infections and Studies (71 papers) and Bacterial biofilms and quorum sensing (55 papers). José L. López-Ribot collaborates with scholars based in United States, Spain and United Kingdom. José L. López-Ribot's co-authors include Gordon Ramage, Brian L. Wickes, Stephen P. Saville, Christopher G. Pierce, Priya Uppuluri, Anna L. Lazzell, Eilidh Mowat, Juan‐Pablo Martínez, Carlos Monteagudo and Thomas F. Patterson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

José L. López-Ribot

192 papers receiving 15.6k citations

Hit Papers

A simple and reproducible 96-well plate-based method for... 1998 2026 2007 2016 2008 2008 2001 1998 2005 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing
    2008 720 citations Christopher G. Pierce, Priya Uppuluri et al. profile →
  2. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing
    2008 674 citations Christopher G. Pierce, Priya Uppuluri et al. profile →
  3. Standardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicans Biofilms
    2001 637 citations Gordon Ramage, José L. López-Ribot et al. profile →
  4. Cell Wall and Secreted Proteins ofCandida albicans: Identification, Function, and Expression
    1998 608 citations W. LaJean Chaffin, José L. López-Ribot et al. profile →
  5. CandidaBiofilms: an Update
    2005 554 citations Gordon Ramage, Stephen P. Saville et al. profile →
  6. Inhibition of Candida albicans Biofilm Formation by Farnesol, a Quorum-Sensing Molecule
    2002 550 citations Gordon Ramage, Stephen P. Saville et al. profile →
  7. EngineeredControl of Cell Morphology In Vivo Reveals Distinct Roles for Yeast andFilamentous Forms of Candida albicans duringInfection
    2003 519 citations Stephen P. Saville, Anna L. Lazzell et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
José L. López-Ribot United States 70 11.1k 6.2k 5.4k 2.1k 1.7k 194 15.9k
Gordon Ramage United Kingdom 64 9.1k 0.8× 4.7k 0.8× 5.6k 1.0× 1.7k 0.8× 2.9k 1.7× 222 16.1k
Bernhard Hube Germany 83 14.9k 1.3× 10.3k 1.7× 6.2k 1.1× 2.9k 1.4× 1.4k 0.8× 301 21.3k
Frank C. Odds United Kingdom 79 15.5k 1.4× 11.0k 1.8× 5.4k 1.0× 2.7k 1.3× 952 0.6× 265 21.3k
Pranab K. Mukherjee United States 50 5.8k 0.5× 3.5k 0.6× 4.0k 0.7× 1.1k 0.5× 1.4k 0.8× 142 11.2k
Dominique Sanglard Switzerland 72 12.6k 1.1× 9.2k 1.5× 5.0k 0.9× 1.6k 0.8× 376 0.2× 227 18.5k
Clarissa J. Nobile United States 43 6.2k 0.6× 3.7k 0.6× 3.0k 0.6× 1.3k 0.6× 917 0.5× 110 8.3k
Shawn R. Lockhart United States 67 11.4k 1.0× 9.5k 1.5× 2.1k 0.4× 1.1k 0.5× 423 0.2× 252 14.0k
Gordon D. Brown United Kingdom 88 12.4k 1.1× 10.4k 1.7× 8.2k 1.5× 1.6k 0.8× 307 0.2× 218 32.1k
Mariana Henriques Portugal 51 3.9k 0.4× 2.3k 0.4× 2.7k 0.5× 2.0k 1.0× 911 0.5× 233 10.3k
Arnaldo Lopes Colombo Brazil 67 12.1k 1.1× 10.0k 1.6× 1.7k 0.3× 861 0.4× 475 0.3× 290 15.1k

Countries citing papers authored by José L. López-Ribot

Since Specialization
Citations

This map shows the geographic impact of José L. López-Ribot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José L. López-Ribot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José L. López-Ribot more than expected).

Fields of papers citing papers by José L. López-Ribot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José L. López-Ribot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José L. López-Ribot. The network helps show where José L. López-Ribot may publish in the future.

Co-authorship network of co-authors of José L. López-Ribot

This figure shows the co-authorship network connecting the top 25 collaborators of José L. López-Ribot. A scholar is included among the top collaborators of José L. López-Ribot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José L. López-Ribot. José L. López-Ribot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wiederhold, Nathan P., et al.. (2025). Drug Discovery and Repurposing for Coccidioides: A Systematic Review. Journal of Fungi. 11(12). 875–875.
2.
Wall, Gina, Bruna Vidal Bonifácio, Ashok K. Chaturvedi, et al.. (2023). High-Throughput Screening of the Repurposing Hub Library to Identify Drugs with Novel Inhibitory Activity against Candida albicans and Candida auris Biofilms. Journal of Fungi. 9(9). 879–879. 7 indexed citations
3.
Ramage, Gordon, Elisa Borghi, Célia F. Rodrigues, et al.. (2023). Our current clinical understanding of Candida biofilms: where are we two decades on?. Apmis. 131(11). 636–653. 16 indexed citations
4.
Lara, Humberto H., et al.. (2019). Activating a Silver Lipoate Nanocluster with a Penicillin Backbone Induces a Synergistic Effect against S. aureus Biofilm. ACS Omega. 4(26). 21914–21920. 7 indexed citations
5.
Vázquez-Muñoz, Roberto, et al.. (2019). Protocol optimization for a fast, simple and economical chemical reduction synthesis of antimicrobial silver nanoparticles in non-specialized facilities. BMC Research Notes. 12(1). 773–773. 30 indexed citations
6.
Uppuluri, Priya, Maikel Acosta‐Zaldívar, Matthew Z. Anderson, et al.. (2018). Candida albicans Dispersed Cells Are Developmentally Distinct from Biofilm and Planktonic Cells. mBio. 9(4). 83 indexed citations
7.
Montelongo‐Jauregui, Daniel, Johnathan J. Abercrombie, Anand Srinivasan, et al.. (2018). Antimicrobial and Antibiofilm Activity of Synergistic Combinations of a Commercially Available Small Compound Library With Colistin Against Pseudomonas aeruginosa. Frontiers in Microbiology. 9. 2541–2541. 38 indexed citations
8.
Lara, Humberto H., David M. Black, Marcos M. Alvarez, et al.. (2018). Tetrahedral (T) Closed-Shell Cluster of 29 Silver Atoms & 12 Lipoate Ligands, [Ag29(R-α-LA)12](3−): Antibacterial and Antifungal Activity. ACS Applied Nano Materials. 1(4). 1595–1602. 35 indexed citations
9.
Romo, Jesús A., Christopher G. Pierce, Ashok K. Chaturvedi, et al.. (2017). Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of Candida albicans Filamentation. mBio. 8(6). 89 indexed citations
10.
Cleary, Ian A., Anna L. Lazzell, Carlos Monteagudo, et al.. (2016). Examination of the pathogenic potential ofC. albicansfilamentous cells in an animal model of haematogenously disseminated candidiasis. FEMS Yeast Research. 16(2). fow011–fow011. 18 indexed citations
11.
Srinivasan, Anand, et al.. (2013). Drug susceptibility of matrix‐encapsulated Candida albicans nano‐biofilms. Biotechnology and Bioengineering. 111(2). 418–424. 11 indexed citations
12.
Chambers, James P., et al.. (2011). Alpha-1 Antitrypsin is Markedly Decreased Following Pulmonary F. tularensis Challenge. Frontiers in Cellular and Infection Microbiology. 1. 20–20. 2 indexed citations
13.
Srinivasan, Anand, Priya Uppuluri, José L. López-Ribot, & Anand K. Ramasubramanian. (2011). Development of a High-Throughput Candida albicans Biofilm Chip. PLoS ONE. 6(4). e19036–e19036. 36 indexed citations
14.
Banerjee, Mohua, Anna L. Lazzell, Patricia L. Carlisle, et al.. (2008). UME6, a Novel Filament-specific Regulator ofCandida albicansHyphal Extension and Virulence. Molecular Biology of the Cell. 19(4). 1354–1365. 211 indexed citations
15.
Murgui, Amelia, et al.. (2006). Biofilm formation byCandida albicansmutants for genes coding fungal proteins exhibiting the eight-cysteine-containing CFEM domain. FEMS Yeast Research. 6(7). 1074–1084. 79 indexed citations
16.
Viudes, A, Anna L. Lazzell, Sofía Perea, et al.. (2004). The C-terminal antibody binding domain ofCandida albicansmp58 represents a protective epitope during candidiasis. FEMS Microbiology Letters. 232(2). 133–138. 25 indexed citations
17.
Viudes, A, Rafael Cantón, Javier Pemán, José L. López-Ribot, & M Gobernado. (2002). Correlación entre las pruebas de sensibilidad in vitro a los antifúngicos y la evolución clínica de los pacientes con candidiasis y criptococosis. Revista española de quimioterapia. Suplemento. 15(1). 32–42. 4 indexed citations
18.
López-Ribot, José L., Joseba Bikandi, Rosario San Millàn, & W. LaJean Chaffin. (1999). Interactions between Candida albicans and the Human Extracellular Matrix Component Tenascin-C. PubMed. 2(1). 58–63. 11 indexed citations
19.
López-Ribot, José L. & W L Chaffin. (1994). Binding of the extracellular matrix component entactin to Candida albicans. Infection and Immunity. 62(10). 4564–4571. 60 indexed citations
20.
Martínez, Juan‐Pablo, José L. López-Ribot, M. Luisa Gil, Rafael Sentandreu, & Jos x E Ruiz-Herrera. (1990). Inhibition of the dimorphic transition of Candida albicans by the ornithine decarboxylase inhibitor 1,4-diaminobutanone: alterations in the glycoprotein composition of the cell wall. Journal of General Microbiology. 136(10). 1937–1943. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gordon Ramage Breakdown of academic impact, for papers by Bernhard Hube Breakdown of academic impact, for papers by Frank C. Odds Breakdown of academic impact, for papers by Pranab K. Mukherjee Breakdown of academic impact, for papers by Dominique Sanglard Breakdown of academic impact, for papers by Clarissa J. Nobile Breakdown of academic impact, for papers by Shawn R. Lockhart Breakdown of academic impact, for papers by Gordon D. Brown Breakdown of academic impact, for papers by Mariana Henriques Breakdown of academic impact, for papers by Arnaldo Lopes Colombo
Rankless by CCL
2026